Skip to content

Tolerance of a Calorically Dense Enteral Nutrition Formula

Tolerance of a Calorically Dense Enteral Nutrition Formula

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02806427
Enrollment
29
Registered
2016-06-20
Start date
2016-06-30
Completion date
2017-03-11
Last updated
2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Feeding

Brief summary

This prospective observational study seeks to demonstrate the ability to meet nutritional needs of a calorically dense enteral formula in critically ill patients.

Interventions

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult aged \> 18 years * Admitted to Medical ICU with expected admission of ≥ 3 days * Established enteral access * Having obtained his/her or legal representative's informed consent.

Exclusion criteria

* Pregnant or lactating * Condition which contraindicates enteral feeding (i.e. intestinal obstruction) * Lack of enteral access * Parenteral nutrition * Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, etc.) * Subject who in the Investigator's assessment cannot be expected to comply with study protocol * Currently participating in another conflicting clinical trial.

Design outcomes

Primary

MeasureTime frame
Daily percentage of caloric nutritional goal metFirst 3 days in the ICU

Secondary

MeasureTime frame
Daily percentage of protein goal metFirst 5 days in the ICU
Adverse events and serious adverse eventsFirst 5 days in the ICU

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026